Exclusive Highlights from ZIYALAN Summit! Full Breakdown of Medical Beauty Device Compliance Registration for Singapore, Malaysia & Thailand - Wiselink Group-A More Controllable, Stable, and Future-Oriented Material Direction

Home > News Center > Exclusive Highlights from ZIYALAN Summit! Full Breakdown of Medical Beauty Device Compliance Registration for Singapore, Malaysia & Thailand

Exclusive Highlights from ZIYALAN Summit! Full Breakdown of Medical Beauty Device Compliance Registration for Singapore, Malaysia & Thailand

Time：2026-07-20 14:03:30

The 9th International Medicine of Anti-aging & Aesthetics Congress (ZIYALAN Summit) has successfully concluded! The special strategic session Overseas Medical Beauty Expansion · New Territory Navigation also came to an end. For those who missed the on-site event and live stream, we have sorted out the complete PPT of the sharing session Compliance Registration Guide for Medical Beauty Products Entering Southeast Asia. This article focuses on three mature core medical beauty markets in Southeast Asia – Singapore, Malaysia and Thailand. It thoroughly analyzes market dividends, unified ASEAN classification standards, core regulatory & registration rules, official fees, review timelines and practical compliance pain points, delivering actionable overseas expansion references for medical beauty device manufacturers.

一、Southeast Asia Medical Beauty Market Overview

According to reports from Research and Markets, the scale of Southeast Asia’s medical beauty market reached USD 7.7 billion in 2025, with a compound annual growth rate (CAGR) of 11.2%, far exceeding the global average. Multiple driving forces fuel the continuous expansion of this market:

Demographic & consumption dividends：Over 50% of Southeast Asia’s population is under 35 years old, with high social media penetration. Local consumers hold an open attitude toward aesthetic treatments and international brands. Thailand’s facial care expenditure accounts for 0.45% of its GDP, surpassing Japan and South Korea by a large margin; Singapore’s per capita spending on facial care ranks second only to South Korea.

Boost from medical beauty tourism：Southeast Asia boasts prominent price advantages for aesthetic treatments. Patients from the US can save up to 80% on procedures in Malaysia and 75% in Thailand, which in turn drives surging demand for upstream medical beauty devices and consumables.

Economic & policy dividends：Southeast Asia’s GDP growth rate generally exceeds 5%. Coupled with sustained benefits brought by RCEP, industrial chain collaboration between China and ASEAN countries runs smoothly, cutting logistics and cross-border trade costs substantially.

Lower compliance barriers：Compared with the stringent approval procedures in Europe and the US, the review process for medical devices in Southeast Asia is much streamlined, making it an ideal testing ground for enterprises to quickly verify product competitiveness overseas.

二、Unified ASEAN Medical Device Classification Standard (AMDD)

Official Definition of Medical Devices

Medical devices refer to instruments, equipment, appliances, materials, software or combinations thereof intended by manufacturers for human use, covering purposes including disease diagnosis, prevention, monitoring, treatment or alleviation; repair, replacement or support of human anatomical structures or physiological functions; life support; contraception; device sterilization; and providing medical information via in vitro testing of human specimens. The primary intended effects of medical devices shall not be achieved through pharmacological, immunological or metabolic means, though such means may assist their functions.

Four-Tier Risk Classification System (Low to High Risk)

Class A (Low Risk), Class B (Low-Moderate Risk), Class C (Moderate-High Risk), Class D (High Risk)Classification is judged based on three core dimensions: invasiveness, duration of human contact, and functional mechanism:

Contact duration: Transient use (less than 60 minutes) = Class A; Short-term use (60 minutes to 30 days) = Class B; Long-term implantation (over 30 days) = Class C or D
Energy & biological properties: Devices delivering ionizing radiation or hazardous energy = Class C; Implantable fillers, products fully or partially absorbable by human bodies, and devices containing animal tissues/derivatives = Class D

Classification Examples of Mainstream Medical Beauty Devices Applicable to Singapore, Malaysia & Thailand

IPL hair removal devices (Singapore, Malaysia, Thailand): Class B
CO₂ laser therapy equipment & radiofrequency skin treatment devices (Malaysia): Class C
Poly-L-lactic acid facial fillers (Thailand): Class 4 (equivalent to ASEAN Class D)

三、Full Registration Rules for Medical Devices with Singapore HSA

Regulatory Authority

The Health Sciences Authority (HSA) under Singapore’s Ministry of Health, established in April 2001. It draws on regulatory frameworks of the US FDA, EU Notified Bodies, Australia TGA and other developed economies, and holds full administrative law enforcement power.

Mandatory Requirements for Registrants

The applicant must be a locally registered Singapore company. Except for exempted products, all medical devices shall be fully registered and listed on the Singapore Medical Device Register (SMDR). The local registrant acts as the sole liaison with HSA and bears full compliance liabilities for the product.

Two Registration Pathways

Exemption Pathway: Non-sterile Class A medical devices are exempted from full registration; enterprises only need to fill in the Class A exemption list via the MEDICS system when applying for distributor licenses. Sterile Class A devices still require complete registration.
Accelerated Review Pathway: For Class B, C and D devices that have obtained marketing approvals from the US, EU, Australia or Japan, the review period can be greatly shortened upon submission of relevant certification documents.

Full List of Application Documents

Letter of Authorization (LOA), product configuration list, Declaration of Conformity, product specifications, verification & validation reports, clinical evaluation report, risk analysis documents, label drafts, manufacturer qualification certificates and other 11 categories of core materials.

Registration Fees & Review Timelines (2026 Exchange Rate: 1 SGD = 5.24 RMB)

四、Full Registration Rules for Medical Devices with Thailand TFDA

Regulatory Authority

The Medical Device Division under Thailand’s Food and Drug Administration (TFDA), which governs the approval, market supervision and safety recall of all types of medical beauty devices, with standards aligned with international best practices.

Legal Liabilities of Local Registrants

Local registrants holding TFDA medical device registration certificates bear full legal responsibility for product safety and quality sold within Thailand. They must continuously update all technical documentation, conduct post-market product follow-up, and implement safety alerts and product recall orders issued by TFDA.

Registration Fees & Review Timelines (2026 Exchange Rate: 1 THB = 0.2 RMB)

五、Full Registration Rules for Medical Devices with Malaysia MDA

Regulatory Authority

The Medical Device Authority (MDA), a federal statutory agency under Malaysia’s Ministry of Health, responsible for enforcing the Medical Device Act 2012. BSI is an official designated Conformity Assessment Body (CAB) authorized to conduct ISO 13485 and Good Distribution Practice for Medical Devices (GDPMD) audits.

Mandatory Local Authorized Representative (AR) Rule

Overseas manufacturers without local Malaysian subsidiaries must appoint a Malaysian Authorized Representative (AR). One single product can only be assigned to one AR. The AR takes charge of registration filing and full post-market clinical follow-up (PMCF) supervision. Enterprises may select an independent third-party AR to avoid confidential technical data being accessed by distributors.

Two Conformity Assessment Pathways

Simplified Verification (SV): Available for products with marketing approvals from any of the five GHTF member regions (EU, US, Japan, Canada, Australia), featuring streamlined review procedures.
Full Confirmation (FC): Mandatory for products without pre-existing overseas market certifications.

Mandatory Application Materials

Product configuration list, Declaration of Conformity, product description, verification & validation reports, clinical evaluation documents, labels & instructions for use, risk analysis reports, and post-market clinical follow-up (PMCF) plan.

Registration Fees & Review Timelines (2026 Exchange Rate: 1 MYR = 1.66 RMB)

六、Conclusion

Singapore, Malaysia and Thailand feature strong consumer purchasing power and mature sales channels, yet each country sets distinct rules regarding local authorized representatives, filing documentation and review cycles. Before overseas expansion, manufacturers shall first classify their medical devices by risk tier in accordance with the ASEAN AMDD regulation, select matching registration pathways, and prioritize the accelerated review track if the product holds existing overseas market certifications to shorten time-to-market. Feel free to contact Wiselink for in-depth one-on-one consultation.

Previous：Which Southeast Asian Market to Prioritize for Medical Device Overseas Expansion? Vietnam, Indonesia and the Philippines In-Depth Analysis Next：Do Not Rush Registration! Summary of Core Compliance Bottlenecks for High-Risk Aesthetic Medical Devices in Australia & the US

Fill Form

Whether you need more information or wish to cooperate with us, we will guide you through every step of the regulatory process. Subscribe to our newsletter for the latest global regulatory updates.